Access cutting-edge focal segmental glomerulosclerosis treatment through this clinical trial at a research site in Alabaster. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Alabaster location
Preparing your pre-screening questions…
Access focal segmental glomerulosclerosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related focal segmental glomerulosclerosis treatment provided free
Check if you qualify for this focal segmental glomerulosclerosis clinical trial in Alabaster, AL
No-Cost Study Care
Local to Alabaster
Convenient for AL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by chance. Every participant has an equal chance of being in each group. One group takes BI 764198 tablets, and the other group takes placebo tablets. Placebo tablets look like BI 764198 tablets but do not contain any medicine. Participants take a tablet once a day for up to 2 years. All participants also continue their standard medication for FSGS. Participants are in the study for up to 2 years. During this time, they visit the study site about every 3 months. Participants regularly collect urine samples. This is done to check their kidneys. The results are compared between the two groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.
Sponsor: Boehringer Ingelheim
Yes, this clinical trial (NCT07220083) has an active research site in Alabaster, AL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for focal segmental glomerulosclerosis treatment options in Alabaster, AL, this clinical trial (NCT07220083) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Alabaster research site is actively enrolling participants for this clinical trial. You'll receive care from experienced focal segmental glomerulosclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all focal segmental glomerulosclerosis clinical trials near you to find additional studies recruiting in your area.
See all nephrotic syndrome clinical trials recruiting in Alabaster — not just this study.
Browse Nephrotic Syndrome Trials in Alabaster →